Announcements Trials
Browse Landscape

Phase

Phase 3 3Phase 2 3Phase 4 2Phase EARLY_PHASE1 1

Status

Enrolling by invitation 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Tumor-Agnostic 2Gynecologic 2Genitourinary 2Gastrointestinal 2Classical hematology 2Sarcoma 1Myeloid 1

Conditions

Venous Thromboembolism 2Sarcoma 1Ovarian Neoplasms 1Hematoma 1Bone Neoplasms 1

Interventions

Epoetin Alfa 8ferric carboxymaltose 6epoetin beta 6Meropenem 6Ceftazidime 5Vancomycin 4Darbepoetin alfa 4apixaban 3Enoxaparin 3Ciprofloxacin 3Cefepime 3iron isomaltoside 1000 2ferrous sulfate 2ferrous fumarate 2Teicoplanin 2Radiotherapy 2Levofloxacin 2Filgrastim 2Dalteparin 2Cholecalciferol 2Aspirin 2Amikacin 2sotorasib 1posaconazole 1ferrous succinate 1ferric gluconate 1eltrombopag 1ceftolozane, tazobactam drug combination 1Vitamin B 12 1Vaccination 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 4 × Aspirin × Classical hematology × Clear all
NCT03244020 2025-10-03

LMWH vs Aspirin for VTE Prophylaxis in Orthopaedic Oncology

Massachusetts General Hospital

Phase 4 Enrolling by invitation
2,868 enrolled
Classical hematologySarcoma

Bone Neoplasms, Hematoma, Sarcoma, Venous Thromboembolism

NCT04352439 2022-09-26

Aspirin for Prevention of Venous Thromboembolism Among Ovarian Cancer Patients Receiving Neoadjuvant Chemotherapy

Duke University

Phase 4 Completed
19 enrolled 10 charts
Classical hematologyGynecologic

Ovarian Neoplasms, Venous Thromboembolism

Data powered by HemOnc (CC BY 4.0) Colophon âš¡